DEF 14A

Company

Whitehawk Therapeutics, Inc.

Filed

June 9, 2021

Period of Report

July 22, 2021

Accession Number

0001564590-21-032185

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →